Announcements Trials
Browse Landscape

Phase

Phase 1 2

Status

Recruiting 2Enrolling by invitation 1

Sponsor Class

NIH 5OTHER 3INDUSTRY 1

Study Type

Interventional 2Observational 1

Sponsor

Cancer Type

CNS 3Sarcoma 1

Conditions

Breast Neoplasms 930Neoplasms 708Prostatic Neoplasms 490Lung Neoplasms 398Carcinoma, Non-Small-Cell Lung 359Colorectal Neoplasms 357Leukemia, Myeloid, Acute 290Pancreatic Neoplasms 238Brain Neoplasms 227Neoplasm Metastasis 221Multiple Myeloma 214Carcinoma, Hepatocellular 199Head and Neck Neoplasms 182Glioblastoma 181Precursor Cell Lymphoblastic Leukemia-Lymphoma 177Melanoma 173Ovarian Neoplasms 168Squamous Cell Carcinoma of Head and Neck 160Uterine Cervical Neoplasms 144Rectal Neoplasms 144Recurrence 142Hematologic Neoplasms 134Sarcoma 133Triple Negative Breast Neoplasms 127Stomach Neoplasms 127Glioma 126Carcinoma, Renal Cell 123Colonic Neoplasms 113Myelodysplastic Syndromes 112Urinary Bladder Neoplasms 109

Interventions

talimogene laherparepvec 1Deoxycholic Acid 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
OTHER × Neurofibroma × 90 days × Clear all
NCT07102394 2026-05-08

Feasibility and Tolerability of IMLYGIC for the Treatment of Cutaneous Neurofibromas in Adults With NF1

Johns Hopkins University

Phase 1 Recruiting
10 enrolled
CNS

Neurofibroma, Neurofibromatosis 1, Neurofibromatoses

NCT06300502 2026-04-22

Assessing the Efficacy of Repeat, Monthly Treatments of Deoxycholate for NF1 Associated Cutaneous Neurofibromas (cNFs)

Massachusetts General Hospital

Phase 1 Enrolling by invitation
15 enrolled
CNS

Neurofibroma, Neurofibromatosis 1

NCT07298083 2026-04-09

DoD Award NF230020 Identification of Metabolic Markers and Statistical Prediction of MPNST for Rapid Diagnosis and Assessment of Surgical Margins

M.D. Anderson Cancer Center

Recruiting
60 enrolled
CNSSarcoma

Neurofibroma, Neurofibrosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡